Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When does sugammadex come off patent?Sugammadex patent expiry?Is lipitor's asp expected to change soon?Sugammadex trade name?Cosopt pf eye drops price?
See the DrugPatentWatch profile for Juluca
Juluca (dolutegravir/rilpivirine) is used to treat HIV-1 infection. It’s prescribed for adults who are already on antiretroviral therapy and have a suppressed viral load (HIV-1 RNA is controlled) with no history of treatment failure and no known resistance to either component. [1]
Doctors typically use Juluca as a switch option, not for starting treatment in every patient. It is meant for people already stable on HIV medicines who meet the criteria for viral suppression and resistance history. [1]
Juluca is a complete antiretroviral regimen in a two-drug combination (an integrase inhibitor plus an NNRTI). That means it’s used as a standalone HIV regimen rather than being mixed with additional antiretroviral drugs unless a clinician specifically changes the plan for resistance, side effects, or interactions. [1]
Patients and clinicians often pay special attention to drug interactions with Juluca, since some medicines can lower rilpivirine levels and make treatment less effective. Time of dosing and whether it’s taken with food can also matter for maintaining effective drug exposure. [1]
[1] https://www.drugs.com/iloca/juluca.html
Other Questions About Juluca :